We are live on ! Find out more
CLSD

Clearside Biomedical
CLSD

Delisted

CLSD was delisted on the 28th of November, 2025.

Back to rankings

45 hedge funds and large institutions have $22.2M invested in Clearside Biomedical in 2020 Q2 according to their latest regulatory filings, with 10 funds opening new positions, 12 increasing their positions, 10 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

43% more first-time investments, than exits

New positions opened: 10 | Existing positions closed: 7

20% more repeat investments, than reductions

Existing positions increased: 12 | Existing positions reduced: 10

13% more capital invested

Capital invested by funds: $19.6M → $22.2M (+$2.59M)

5% more funds holding

Funds holding: 43 → 45 (+2)

0.04% more ownership

Funds ownership: 1.71% → 1.75% (+0.04%)

99% less call options, than puts

Call options by funds: $14K | Put options by funds: $1.54M

Holders
45
Holders Change
+2
Holders Change %
+4.65%
% of All Funds
0.92%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
10
Increased
12
Reduced
10
Closed
7
Calls
$14K
Puts
$1.54M
Net Calls
-$1.53M
Net Calls Change
+$142K

Top Buyers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
+$822K
2
Two Sigma Investments
Two Sigma Investments
New York
+$242K
3
BCM
Bridgeway Capital Management
Texas
+$185K
4
Group One Trading
Group One Trading
Illinois
+$179K
5
Millennium Management
Millennium Management
New York
+$144K

Top Sellers

Rank Fund Capital Flow
1
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$913K
2
Morgan Stanley
Morgan Stanley
New York
-$443K
3
Vanguard Group
Vanguard Group
Pennsylvania
-$85.1K
4
CG
Carmignac Gestion
France
-$84.2K
5
FAM
Fred Alger Management
New York
-$68K
Name Holding Trade Value Shares
Change 		Change in
Stake
WS
26
Wedbush Securities
California
$43K – – –
Bank of New York Mellon
27
Bank of New York Mellon
New York
$39K – – –
JIC
28
Johnson Investment Counsel
Ohio
$38K +$39.3K +1,333 New
AG
29
Aperio Group
California
$35K +$6.3K +214 +21%
Stifel Financial
30
Stifel Financial
Missouri
$34K +$9.69K +329 +38%
UBS Group
31
UBS Group
Switzerland
$30K -$4.15K -141 -12%
IAN
32
Integrated Advisors Network
Texas
$30K – – –
FCBT
33
First Citizens Bank & Trust
North Carolina
$28K +$29.4K +1,000 New
Simplex Trading
34
Simplex Trading
Illinois
$26K -$2.15K -73 -7%
VF
35
Virtu Financial
New York
$25K +$26.1K +886 New
DADC
36
D.A. Davidson & Co
Montana
$20K +$20.6K +700 New
JP Morgan Chase
37
JP Morgan Chase
New York
$9K – – –
Osaic Holdings
38
Osaic Holdings
Arizona
$5K -$501 -17 -10%
TFS
39
TrustCore Financial Services
Tennessee
$4K – – –
PA
40
Parallel Advisors
California
$3K – – –
Royal Bank of Canada
41
Royal Bank of Canada
Ontario, Canada
$3K +$265 +9 +10%
CG
42
Cutler Group
California
$2K – – –
TRCT
43
Tower Research Capital (TRC)
New York
$2K +$2.21K +75 New
BNP Paribas Financial Markets
44
BNP Paribas Financial Markets
France
$15 -$88 -3 -75%
FAM
45
Fred Alger Management
New York
– -$68K -2,667 Closed
AG
46
Algert Global
California
– -$43K -1,695 Closed
Victory Capital Management
47
Victory Capital Management
Texas
– -$22K -840 Closed
DLHL
48
Donald L. Hagan LLC
Florida
– -$24K -667 Closed
MWM
49
MinichMacGregor Wealth Management
New York
– -$24K -667 Closed
BC
50
Barnett & Company
Tennessee
– -$7K -273 Closed
1
2
3

CLSD Hedge Fund Activity: Q2 2020 in Review

45 of the 4,877 institutional investors tracked by Wall St. Rank reported a position in Clearside Biomedical (CLSD) for Q2 2020, worth a combined $22.2M — up 13% from $19.6M a quarter earlier.

Buyers outnumbered sellers: 10 funds opened new CLSD positions and 7 closed out — a net gain of 3 holders — while 12 added to existing stakes and 10 trimmed.

The largest buyer was Renaissance Technologies, adding an estimated $822K. The largest seller was Susquehanna International Group, cutting an estimated $913K.

  • 45 institutional investors held Clearside Biomedical (CLSD) as of Q2 2020, up from 43 in Q1 2020.
  • Funds reported $22.2M of Clearside Biomedical stock for Q2 2020, up 13% quarter-over-quarter.
  • 10 funds opened new Clearside Biomedical positions in Q2 2020 and 7 closed out, a net change of +3 holders.
  • The largest Clearside Biomedical buyer in Q2 2020 was Renaissance Technologies, an estimated $822K added.
  • The largest Clearside Biomedical seller in Q2 2020 was Susquehanna International Group, an estimated $913K sold.

Based on aggregated 13F filings for Q2 2020.